Knight Therapeutics Stock Investor Sentiment

KHTRF Stock  USD 3.73  0.02  0.53%   
Roughly 62% of Knight Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Knight Therapeutics pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Knight Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Knight Therapeutics stock news signals to limit their universe of possible portfolio assets.
Knight Therapeutics pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Knight daily returns and investor perception about the current price of Knight Therapeutics as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Knight Therapeutics Reports First Quarter 2023 Results - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Knight Therapeutics Inc. announces voting results from the Annual ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City - Ma...
Google News at Macroaxis
over a year ago at news.google.com         
Glen Eagle Resources Announces Appointment of New Director to the Board - Investing News Network
Google News at Macroaxis
over a year ago at news.google.com         
Ardelyx Reports First Quarter 2023 Financial Results and Provides Business Update - Marketscreener.c...
Google News at Macroaxis
over a year ago at news.google.com         
Ardelyx Announces Additional Data Supporting First-In-Class IBSRELA for Adults with IBS-C, to be Pre...
Google News at Macroaxis
over a year ago at news.google.com         
Outlook Therapeutics August PDUFA For Wet AMD Blockbuster ... - Seeking Alpha
Google News at Macroaxis
over a year ago at news.google.com         
Ardelyx to Report First Quarter 2023 Financial Results and Provide Business Update on May 3, 2023 - ...
Google News at Macroaxis
over a year ago at news.google.com         
Abbott Reports First-Quarter 2023 Results Increases Outlook For Underlying Base Business - Investing...
Google News at Macroaxis
over a year ago at news.google.com         
Knight to Present at the 2023 Bloom Burton Co. Healthcare Investor Conference - Investing News Netwo...
Google News at Macroaxis
over a year ago at news.google.com         
This Is The Biggest Risk For Investors In 2023 According To Knight Franks New Wealth Report, But Exp...
Google News at Macroaxis
over a year ago at news.google.com         
Alimera Sciences Announces 2022 Financial Results and Business Update - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Insiders may be rethinking their CA886k Knight Therapeutics Inc. investment now that the company has...
Google News at Macroaxis
over a year ago at news.google.com         
Dont Mess with Your Melon Abbott and the Brain Injury Association of America Urge If You Hit Your He...
Google News at Macroaxis
over a year ago at news.google.com         
While insiders own 21 percent of Knight Therapeutics Inc. TSEGUD ... - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Knight Therapeutics that are available to investors today. That information is available publicly through Knight media outlets and privately through word of mouth or via Knight internal channels. However, regardless of the origin, that massive amount of Knight data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Knight Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Knight Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Knight Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Knight Therapeutics alpha.

Knight Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Knight Pink Sheet analysis

When running Knight Therapeutics' price analysis, check to measure Knight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Knight Therapeutics is operating at the current time. Most of Knight Therapeutics' value examination focuses on studying past and present price action to predict the probability of Knight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Knight Therapeutics' price. Additionally, you may evaluate how the addition of Knight Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stocks Directory
Find actively traded stocks across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation